Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy

The American Journal of Cardiology
P H Frost, R J Havel

Abstract

The plasma level of low-density lipoprotein (LDL) cholesterol is the "gold standard" for estimating the lipoprotein-related risk for complications of atherosclerotic vascular disease. LDL cholesterol concentrations are commonly estimated by the Friedewald formula that requires only the measurement (after overnight fasting) of plasma cholesterol and triglycerides along with high-density lipoprotein (HDL) cholesterol. This value, however, is not in fact a true estimate of LDL cholesterol but rather of LDL cholesterol along with variable, usually smaller, amounts of intermediate-density lipoprotein (IDL) cholesterol and lipoprotein(a). Estimation of LDL cholesterol levels by the Friedewald formula becomes progressively less accurate as plasma triglyceride concentrations increase, and the formula is generally considered inapplicable when triglyceride levels exceed 400 mg/dL. We believe that a very simple measurement-non-HDL cholesterol (serum cholesterol minus HDL cholesterol)-has considerable potential as a screening tool for identifying dyslipoproteinemias, for risk assessment, and for assessing the results of hypolipidemic therapy. Unlike the estimation of LDL cholesterol levels by the Friedewald formula, the estimation of non-H...Continue Reading

References

Dec 1, 1990·Baillière's Clinical Endocrinology and Metabolism·A Hamsten
Feb 1, 1990·Diabetes Care·A Garg, S M Grundy
Sep 1, 1990·Arteriosclerosis : an Official Journal of the American Heart Association, Inc·G L Vega, S M Grundy
Jun 1, 1995·The New England Journal of Medicine·R J Havel, E Rapaport
Oct 1, 1994·Atherosclerosis·J R Patsch
Apr 1, 1994·Current Opinion in Lipidology·R J Havel

❮ Previous
Next ❯

Citations

Oct 8, 1999·Clinica Chimica Acta; International Journal of Clinical Chemistry·A D Sniderman, K Cianflone
Apr 21, 2005·Annals of Epidemiology·F BarziUNKNOWN Asia Pacific Cohort Studies Collaboration
Oct 19, 2004·The Journal of Clinical Investigation·Scott M Grundy
Nov 19, 2010·International Journal of Sports Medicine·J S WootenJ J Barbee
Jan 1, 2005·Indian Journal of Clinical Biochemistry : IJCB·M CariappaH P Kedilaya
Feb 15, 2005·International Journal of Clinical Practice·T Teramoto, C Watkins
Jan 24, 2003·Clinical Cardiology·Jonathan IsaacsohnYale B Mitchel
Sep 15, 2011·Circulation Journal : Official Journal of the Japanese Circulation Society·Hiroshi WatanabeMakoto Kodama
Mar 19, 2014·Journal of Clinical Lipidology·Ranita E KuryanGraeme R Frank
May 4, 2010·Mayo Clinic Proceedings·Charles R Harper, Terry A Jacobson
Aug 1, 2008·Journal of Clinical Lipidology·Michael J BlahaUNKNOWN National Lipid Association Taskforce on Non-HDL Cholesterol
Mar 13, 2014·Diabetic Medicine : a Journal of the British Diabetic Association·I Wakabayashi
Aug 26, 1998·The American Journal of Medicine·M H CriquiR M Krauss
Apr 8, 2003·The American Journal of Cardiology·Donald M Black
Oct 10, 2006·The American Journal of Cardiology·Stanley H HsiaMartin L Lee
Mar 18, 2004·Primary Care·Michael L Green
Aug 18, 2000·The American Journal of Cardiology·E SteinM Mercuri
Apr 2, 2003·The American Journal of Cardiology·Glenn A Hirsch, Roger S Blumenthal
Jan 8, 2011·The American Journal of Cardiology·William C RobertsRonald Viggiani
Apr 30, 2005·Preventive Cardiology·George A KelleyZung Vu Tran
Jan 21, 2006·Seminars in Dialysis·Jia Liu, Mitchell H Rosner
Jul 8, 2008·Journal of Atherosclerosis and Thrombosis·Hitoshi ShimanoNobuhiro Yamada
Oct 16, 2007·Journal of the American College of Cardiology·Matthew A AllisonMichael H Criqui
Jun 3, 2008·Journal of Vascular Surgery·Matthew A AllisonMichael H Criqui
Apr 26, 2015·Journal of Clinical Lipidology·Terry A JacobsonW Virgil Brown
Feb 22, 2014·Journal of Diabetes and Metabolic Disorders·Ramin Alemzadeh, Jessica Kichler

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.